[1] Johnson R, Gretch D, Ramabe H, et al. Memranoproliferative glomerulonephritis associated with hepatitis C virus infection[J].Ibid, 1993, 328∶465-470.
|
[2] D’AmicoG , FornasieriA .Cryoglobulinemicglomerulonephritis:amem branoproliferativeglomerulonephritisinducedbyhepatitisCinfection[J].AmJKidneyDis, 1995, 25∶361-369.
|
[3] Stehman-Breen C, Johnson R. Hepatitis C virus-associated glomerulonephritis[J]. Adv Intern Med, 1998, 43∶79-97.
|
[4] Biesemier K, Falk J, Folds J, et al. Prevalence of antibodyies to hepatitis C in patients with glomerular disease[J]. Lab Invest, 1994, 70∶157A.
|
[5] Koзовскаяв, мухинНА, гордовскаяНБ, идр.Факторрискаирогрессированиякриогобуинемическогогомеруонефрита, связанногосвирусомгеиатитаС[J].КинМед, 2001, 79 (4) ∶32-35.
|
[6] GalliM. Viruses and cryoglobulinemia[J].Clin Exp Rheumatol, 1995, 13∶63-70.
|
[7] Agnello V. Hepatitis C virus infection and type Ⅱ cryoglobulinemia:an immunological perspective[J]. Hepatology, 1997, 26∶1375-1379.
|
[8] Верме bAE .Kриогобуиныикриогобуинемия[J].КинМед, 2000, 78 (2) ∶14-19.
|
[9] Tarantino A, Campise M, Banfi G, et al. Longterm predictors of survival inessential mixed cryoglobulinemic glomerulonephritis[J].Kidneylnt, 1995, 47∶618-623.
|
[10] ГордовскаяНЪ, АзароваВВ, АртемвеваВб, идр.Особенностикиническоготечениянефритауьоьныхскриогобуинемией[J].TepApx, 1997, (6) ∶30-34.
|
[11] Cueto-Manzano A, Poo JL. Hepatitis C virus infection and membranoproliferative glomerulonephritis[J].Rev Invest Clin, 1995, 47 (3) ∶189-196.
|
[12] RothD .HepatitisCvirus:thenephrologyist’sview[J].AmJKidneyDis, 1995, 25∶3-16.
|
[13] МаышкоЕЮ, КонстантиноваНА, СеменоваЕН.Криогобуинемия, ассоцированнаясHCV -инфекцией[J].КинМед, 2001, 79 (1) ∶9-14.
|
[14] Misiani R, Bellavita P. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus[J].N Engl J Med, 1994, 330∶751-756.
|
[15] Tavoni A, Mosca M. Guidelines of the management of essential mixed cryoglobulinemia[J].Clin Exp Rheumatol, 1995, 13∶191-195.
|